Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials | |
Luan, Shuxin; Wan, Hongquan; Zhang, Lei; Zhao, Hua | |
刊名 | NEUROPSYCHIATRIC DISEASE AND TREATMENT
![]() |
2018 | |
卷号 | 14 |
关键词 | treatment-resistant depression adjunctive aripiprazole meta-analysis |
ISSN号 | 1178-2021 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3536229 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Luan, Shuxin,Wan, Hongquan,Zhang, Lei,et al. Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials[J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT,2018,14. |
APA | Luan, Shuxin,Wan, Hongquan,Zhang, Lei,&Zhao, Hua.(2018).Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials.NEUROPSYCHIATRIC DISEASE AND TREATMENT,14. |
MLA | Luan, Shuxin,et al."Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials".NEUROPSYCHIATRIC DISEASE AND TREATMENT 14(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论